Dakshidin Corporatio

Healthcare US DKSC

0.0004USD
0.00(0%)

Last update at 2026-06-19T20:00:00Z

Day Range

0.00050.0005

LowHigh

52 Week Range

0.00010.0007

LowHigh

Fundamentals

Previous Close 0.0004
Market Cap1.79M
Volume2129
P/E Ratio-
Dividend Yield-%
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2025-12-31	2024-03-31	2023-12-31	2023-03-31	2022-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-03-31	2023-12-31	2023-03-31	2022-12-31
Income before tax	-0.04133M	-0.01772M	-0.01772M	-0.16709M	-0.16709M
Minority interest	-	-	-	-	-
Net income	-0.04133M	-0.01772M	-0.01772M	-0.16709M	-0.16709M
Selling general administrative	-	-	-	-	-
Selling and marketing expenses	-	-	-	-	-
Gross profit	-	-	-	-	-
Reconciled depreciation	-	-	-	-	-
Ebit	-	-	-0.01772M	-	-0.39558M
Ebitda	-0.04133M	-0.01772M	0.15M	-0.16709M	-0.16709M
Depreciation and amortization	-	-	0.17M	-	0.23M
Non operating income net other	-	-	-	-	-
Operating income	-0.04133M	-0.01772M	-0.01772M	-0.16709M	-0.16709M
Other operating expenses	0.04M	0.02M	0.02M	0.17M	0.17M
Interest expense	-	-	-	-	-
Tax provision	-	-	-	-	-
Interest income	-	-	-	-	-
Net interest income	-	-	-	-	-
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-0.16789M	-	-0.22848M
Total revenue	-	-	-	-	-
Total operating expenses	0.04M	0.02M	0.02M	0.17M	0.17M
Cost of revenue	-	-	-	-	-
Total other income expense net	-	-	-	-0.00000M	-0.00000M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-	-	-	-	-
Net income applicable to common shares	-	-	-	-	-
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2025-12-31	2024-03-31	2023-12-31	2023-03-31	2022-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-03-31	2023-12-31	2023-03-31	2022-12-31
Total assets	-	0.42M	0.42M	0.53M	0.53M
Intangible assets	-	-	0.41M	-	0.41M
Earning assets	-	-	-	-	-
Other current assets	-	-	-	0.11M	0.11M
Total liab	-	0.41M	0.41M	0.51M	0.51M
Total stockholder equity	-	0.00679M	0.00679M	0.02M	0.02M
Deferred long term liab	-	-	-	-	-
Other current liab	-	0.24M	0.24M	0.28M	0.28M
Common stock	-	2.91M	2.91M	1.21M	1.21M
Capital stock	-	-	-	-	-
Retained earnings	-	-1.51108M	-1.51108M	-1.49336M	-1.49336M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	-	0.00000M	0.00000M	-	-
Cash	-	-0.00002M	-0.00002M	0.00568M	0.00568M
Cash and equivalents	-	-	-	-	-
Total current liabilities	-	0.41M	0.41M	0.51M	0.51M
Current deferred revenue	-	-	-	-	-
Net debt	-	0.15M	0.15M	0.14M	0.14M
Short term debt	-	0.15M	0.15M	0.15M	0.15M
Short long term debt	-	-	-	-	-
Short long term debt total	-	0.15M	0.15M	0.15M	0.15M
Other stockholder equity	-	-1.38754M	-1.38754M	0.31M	0.31M
Property plant equipment	-	-	-	-	-
Total current assets	-	-0.00002M	-0.00002M	0.12M	0.12M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	-	-
Short term investments	-	-	-	-	-
Net receivables	-	-	-	-	-
Long term debt	-	-	-	-	-
Inventory	-	-	-	-	-
Accounts payable	-	0.02M	0.02M	0.08M	0.08M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	0.41M	-0.00000M	0.41M	0.41M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	-	0.42M	0.42M	0.42M	0.42M
Capital lease obligations	-	-	-	-	-
Long term debt total	-	-	-	-	-

Breakdown	2024-03-31	2023-12-31	2023-03-31	2022-12-31	2022-03-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-03-31	2023-12-31	2023-03-31	2022-12-31	2022-03-31
Investments	-	-	-	-	-
Change to liabilities	-	-	-	-	-
Total cashflows from investing activities	-	-	-	-	-
Net borrowings	-	-	-	-	-
Total cash from financing activities	-	-	-0.03428M	-0.03428M	0.34M
Change to operating activities	-	-	-	-	-
Net income	-0.01772M	-0.01772M	-0.16709M	-0.16709M	-0.21684M
Change in cash	-0.00570M	-0.00570M	-0.00390M	-0.00390M	-0.01273M
Begin period cash flow	0.00568M	0.00568M	0.00958M	0.00958M	0.02M
End period cash flow	-0.00002M	-0.00002M	0.00568M	0.00568M	0.00958M
Total cash from operating activities	-0.00570M	-0.00570M	0.03M	0.03M	-0.35025M
Issuance of capital stock	-	-	-	-	-
Depreciation	-	-	-	-	-
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-	-	-	-	0.06M
Change to account receivables	-0.09909M	-0.09909M	-	-	-
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-	-	-	-0.03428M	-
Change to netincome	-	-	-	-	-
Capital expenditures	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.01M	0.01M	0.20M	0.20M	-0.13341M
Stock based compensation	-	-	-	-	-
Other non cash items	0.10M	0.10M	-0.10858M	-0.10858M	-0.06659M
Free cash flow	-0.00570M	-0.00570M	0.03M	0.03M	-0.35025M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)
DKSC Dakshidin Corporatio	- -%	0.0004	-	-	-	-
ZTS Zoetis Inc	-2.82 3.58%	75.89	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	-0.19 0.62%	30.56	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	157.12	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	- -%	42.94	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.

Dakshidin Corporatio

2250 NW 114th Avenue, Miami, FL, United States, 33172-3652

888-818-9167

Key Executives

Name	Title	Year Born
Mr. Christopher Robin Haigh	CEO & Director	NA
Mr. Charles L. Nuzum Sr., CPA	CFO & Sec. to the Board of Directors	1949
Mr. Robert Mack Peak	Chief Marketing Officer	NA
Mr. Charles L. Nuzum Sr., CPA	CFO & Secretary to the Board of Directors	1949
Mr. Samuel J. Butero	Chief Operating Officer	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.